Clinical and Public Health
eSTI2 aims to reduce STI incidence by facilitating the translation and adoption of leading edge, rapid, point of care or self test STI diagnostics. However, significant or perceived regulatory, ethical and economic barriers may delay integration of these tools into mainstream NHS practice. We will investigate these potential barriers in order to provide recommendations on pathways for adoption of this and future novel diagnostic and management pathways into routine care. In addition, we will develop novel wireless and web based technologies to provide individuals and their partners with optimized access to remote STI management. We will also assess the impact of changing the location, mode and context of diagnosis on clinical and surveillance pathways. Findings will inform technological development of mobile-interfacing rapid diagnostics and enable us to conduct community-based feasibility studies in preparation for randomized trials of the effectiveness and cost-effectiveness of these new pathways.